Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Revive Therapeutics (TSE:RVV)
:RVV
Holding TSE:RVV?
Track your performance easily
RVV Stock Chart & Stats
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.04
Previous CloseN/A
Volume2.50K
Average Volume (3M)250.88K
Market Cap
C$4.19M
Enterprise ValueN/A
Total Cash (Recent Filing)$1.77M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.84
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding418,564,270
10 Day Avg. Volume73,058
30 Day Avg. Volume250,881
Standard Deviation0.38
R-Squared0.00068
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Revive Therapeutics News
PremiumCompany Announcements
Revive Therapeutics Advances Research on Bucillamine for Nerve Agent Exposure
PremiumCompany Announcements
Revive Therapeutics Explores Psilocybin for Stroke Treatment
PremiumCompany Announcements
Revive Therapeutics Prioritizes Bucillamine Development
PremiumCompany Announcements
Revive Therapeutics Explores Bucillamine for Nerve Agents and Viral ThreatsOptions Prices
Currently, No data available
---
Ownership Overview
0.88% Insiders
<0.01% Other Institutional Investors
99.12% Public Companies and
Individual Investors
RVV FAQ
What was Revive Therapeutics’s price range in the past 12 months?
Revive Therapeutics lowest stock price was <C$0.01 and its highest was C$0.04 in the past 12 months.
What is Revive Therapeutics’s market cap?
Revive Therapeutics’s market cap is C$4.19M.
When is Revive Therapeutics’s upcoming earnings report date?
Revive Therapeutics’s upcoming earnings report date is Feb 26, 2025 which is in 35 days.
How were Revive Therapeutics’s earnings last quarter?
Currently, no data Available
Is Revive Therapeutics overvalued?
According to Wall Street analysts Revive Therapeutics’s price is currently Overvalued.
Does Revive Therapeutics pay dividends?
Revive Therapeutics does not currently pay dividends.
What is Revive Therapeutics’s EPS estimate?
Revive Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Revive Therapeutics have?
Revive Therapeutics has 418,564,270 shares outstanding.
What happened to Revive Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Revive Therapeutics?
Currently, no hedge funds are holding shares in TSE:RVV
---
Company Description
Revive Therapeutics
Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.
---
Technical Analysis
Aequus Pharmaceuticals
―
Reliq Health Technologies
―
Numinus Wellness
―
Medexus Pharmaceuticals Inc
―
---